Cargando…
Moving forward on the pathway of cell-based therapies in ischemic heart disease and heart failure – time for new recommendations?
Although substantial advances have been made in treating ischemic heart disease and subsequent heart failure, the overall morbidity and mortality from these conditions remain high. Stem cell-based therapy has emerged as a promising approach for prompting cardiac rejuvenation. Various cell types have...
Autor principal: | Micheu, Miruna Mihaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716081/ https://www.ncbi.nlm.nih.gov/pubmed/31523365 http://dx.doi.org/10.4252/wjsc.v11.i8.445 |
Ejemplares similares
-
Disease Models & Mechanisms helps move heart failure to heart success
por: Hooper, Kirsty, et al.
Publicado: (2022) -
Exploring Enhanced Cell-Based Therapy for Ischemic Heart Disease and Heart Failure
por: Madonna, Rosalinda
Publicado: (2022) -
Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease
por: Dorobantu, Maria, et al.
Publicado: (2017) -
Heart Failure and Breast Cancer Therapies: Moving Towards Personalized Risk Assessment
por: Francis, Sanjeev A., et al.
Publicado: (2014) -
Inflammatory markers in acute myocardial infarction and the correlation with the severity of coronary heart disease
por: Oprescu, Nicoleta, et al.
Publicado: (2021)